AGM/EGM18 Jun 2026, 06:10 pm
Akums Drugs files FY26 Integrated Annual Report & 22nd AGM Notice
AI Summary
Akums Drugs and Pharmaceuticals Ltd has filed its Integrated Annual Report for FY 2025-26, along with the notice for its 22nd Annual General Meeting. The AGM is scheduled for Friday, July 10, 2026, at 11:00 A.M. (IST) through Video Conferencing. The report details the company's focus on manufacturing excellence, complex formulations, and global expansion. Key initiatives include a joint venture with the Government of Zambia to establish a pharmaceutical manufacturing plant and successful completion of audits for entry into European markets.
Key Highlights
- Integrated Annual Report for FY 2025-26 has been filed.
- 22nd Annual General Meeting scheduled for July 10, 2026, via virtual means.
- Company is focusing on global expansion and manufacturing excellence.
- Established a joint venture with the Government of Zambia for a manufacturing plant.
- Successfully completed audits for entry into European regulated markets.
Price Impact
More from AKUMS